CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 251,835 shares (other)
- 4 Grant or award Director acquired 6,390 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 194,271 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition Director acquired 3,757,430 shares (other)
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President and CEO gave up 40,880 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,781 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel & Secretary gave up 9,510 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,891 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel & Secretary gave up 4,755 shares (to pay taxes)
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 3,783 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 9 of 36 · 720 filings